Loading…
Reported covered position: Vice President, Federal Affairs
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
New Markets Tax Credit Extension Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)
New Markets Tax Credit Extension Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE COOK GROUP INC. via THE COOK GROUP INC.
2026 · third_quarter · Q3
PFAS issues: Fluoro Polymers [Per- and polyfluoroalkyl] (PFAS) type(s) of substances used in medical devices
Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)
Source: Senate LDA
New Markets Tax Credit Extension Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)
Rural Physician Workforce Production Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153)
Rural Physician Workforce Production Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities CMS NPRM IPPS proposal to repeal New Technology Add on Payment (NTAP) and Transitional Pass-Through pathway for FDA Breakthrough Devices; proposal for adoption of unique device identifier (UDI) capture measure under the Medicare Promoting Interoperability Program. Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153)
Rural Physician Workforce Production Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities CMS NPRM IPPS proposal to repeal New Technology Add on Payment (NTAP) and Transitional Pass-Through pathway for FDA Breakthrough Devices; proposal for adoption of unique device identifier (UDI) capture measure under the Medicare Promoting Interoperability Program. Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153) Medicare Program: Regulatory Alignment for Predictable and Immediate Device Coverage Pathway (RAPID) Proposed Coverage Pathway proposal by CMS
Medical Device Electronic Labeling Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI. Right-to-Repair provision in House NDAA (H.R.4784/H.R. 8800) broadly would impact FDA regulated medical devices
Medical Device Electronic Labeling Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI.
Medical Device Electronic Labeling Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI. Right-to-Repair provision in House NDAA H.R.4784/H.R. 8800 broadly would impact FDA regulated medical devices
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665) U.S.-China Board of Trade
Name, Image and Likeness (NIL) issue: "SCORE Act" (H.R. 4312)
Name, Image and Likeness (NIL) issue: "SCORE Act" (H.R. 4312)
Name, Image and Likeness (NIL) issue: "SCORE Act" (H.R. 4312)
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI.
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI. Right-to-Repair provision in House NDAA (H.R.4784/H.R. 8800) broadly would impact FDA regulated medical devices
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI. Right-to-Repair provision in House NDAA H.R.4784/H.R. 8800 broadly would impact FDA regulated medical devices
Resident Physician Shortage Reduction Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI. Right-to-Repair provision in House NDAA H.R.4784/H.R. 8800 broadly would impact FDA regulated medical devices
Resident Physician Shortage Reduction Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI.
Resident Physician Shortage Reduction Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI. Right-to-Repair provision in House NDAA (H.R.4784/H.R. 8800) broadly would impact FDA regulated medical devices
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI. Right-to-Repair provision in House NDAA H.R.4784/H.R. 8800 broadly would impact FDA regulated medical devices
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI. Right-to-Repair provision in House NDAA (H.R.4784/H.R. 8800) broadly would impact FDA regulated medical devices
Ensuring Patient Access to Critical Breakthrough Products Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities CMS NPRM IPPS proposal to repeal New Technology Add on Payment (NTAP) and Transitional Pass-Through pathway for FDA Breakthrough Devices; proposal for adoption of unique device identifier (UDI) capture measure under the Medicare Promoting Interoperability Program. Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153) Medicare Program: Regulatory Alignment for Predictable and Immediate Device Coverage Pathway (RAPID) Proposed Coverage Pathway proposal by CMS
Ensuring Patient Access to Critical Breakthrough Products Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities CMS NPRM IPPS proposal to repeal New Technology Add on Payment (NTAP) and Transitional Pass-Through pathway for FDA Breakthrough Devices; proposal for adoption of unique device identifier (UDI) capture measure under the Medicare Promoting Interoperability Program. Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153)
Ensuring Patient Access to Critical Breakthrough Products Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153)
National Defense Authorization Act for Fiscal Year 2027
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI. Right-to-Repair provision in House NDAA H.R.4784/H.R. 8800 broadly would impact FDA regulated medical devices
National Defense Authorization Act for Fiscal Year 2027
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI. Right-to-Repair provision in House NDAA (H.R.4784/H.R. 8800) broadly would impact FDA regulated medical devices
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665) U.S.-China Board of Trade
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities CMS NPRM IPPS proposal to repeal New Technology Add on Payment (NTAP) and Transitional Pass-Through pathway for FDA Breakthrough Devices; proposal for adoption of unique device identifier (UDI) capture measure under the Medicare Promoting Interoperability Program. Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153) Medicare Program: Regulatory Alignment for Predictable and Immediate Device Coverage Pathway (RAPID) Proposed Coverage Pathway proposal by CMS
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities CMS NPRM IPPS proposal to repeal New Technology Add on Payment (NTAP) and Transitional Pass-Through pathway for FDA Breakthrough Devices; proposal for adoption of unique device identifier (UDI) capture measure under the Medicare Promoting Interoperability Program. Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153)
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
H.R. 1 the "One Big Beautiful Bill Act" specifically the TCJA Provisions: corporate tax rate; incentives to promote U.S. manufacturing; research and development amortization; bonus depreciation; construction of workforce housing; new market tax credit (H.R. 1103)
New Markets Tax Credit Extension Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
H.R. 1 the "One Big Beautiful Bill Act" specifically the TCJA Provisions: corporate tax rate; incentives to promote U.S. manufacturing; research and development amortization; bonus depreciation; construction of workforce housing; new market tax credit (H.R. 1103)
New Markets Tax Credit Extension Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
TCJA Provisions: corporate tax rate; incentives to promote U.S. manufacturing; research and development amortization; bonus depreciation; construction of workforce housing; new market tax credit (H.R. 1103)
New Markets Tax Credit Extension Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)
New Markets Tax Credit Extension Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)
Medical Device Electronic Labeling Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (legislation pending); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT) Unique Device Identifier (UDI) in Medicare claims form FDA Reform: Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) FDA Modernization: modeling non-animal studies for medical device studies; Medical Device Electronic Labeling Act (H.R. 1539) Biotechnology: reduce regulatory barriers; align public-private investment Nursing Workforce Shortage
Medical Device Electronic Labeling Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT) Unique Device Identifier (UDI) in Medicare claims form FDA Reform: Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) FDA Modernization: modeling non-animal studies for medical device studies; Medical Device Electronic Labeling Act (H.R. 1539); draft legislation "Safe Medical Device Repair Act" third party right to repair Biotechnology: reduce regulatory barriers; align public-private investment Nursing Workforce Shortage
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)
Name, Image and Likeness (NIL) issue: "SCORE Act" H.R. 4312
Name, Image and Likeness (NIL) issue: "SCORE Act" H.R. 4312
Ensuring Patient Access to Critical Breakthrough Products Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement.
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT) Unique Device Identifier (UDI) in Medicare claims form FDA Reform: Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) FDA Modernization: modeling non-animal studies for medical device studies; Medical Device Electronic Labeling Act (H.R. 1539); draft legislation "Safe Medical Device Repair Act" third party right to repair Biotechnology: reduce regulatory barriers; align public-private investment Nursing Workforce Shortage
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the "American Privacy Rights Act of 2024" provisions covering biomedical research and HIPAA
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization; FDA modernization
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the "American Privacy Rights Act of 2024" provisions covering biomedical research and HIPAA
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the "American Privacy Rights Act of 2024" provisions covering biomedical research and HIPAA
American Innovation and R&D Competitiveness Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
American Innovation and R&D Competitiveness Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
American Innovation and R&D Competitiveness Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
American Innovation and R&D Competitiveness Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Affordable Housing Credit Improvement Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Affordable Housing Credit Improvement Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Affordable Housing Credit Improvement Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Affordable Housing Credit Improvement Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Medical Device Electronic Labeling Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the "American Privacy Rights Act of 2024" provisions covering biomedical research and HIPAA
Medical Device Electronic Labeling Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization; FDA modernization
Medical Device Electronic Labeling Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the "American Privacy Rights Act of 2024" provisions covering biomedical research and HIPAA
Medical Device Electronic Labeling Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the "American Privacy Rights Act of 2024" provisions covering biomedical research and HIPAA
Rural Opportunity Zone and Investment Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Rural Opportunity Zone and Investment Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Rural Opportunity Zone and Investment Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Rural Opportunity Zone and Investment Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the "American Privacy Rights Act of 2024" provisions covering biomedical research and HIPAA
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the "American Privacy Rights Act of 2024" provisions covering biomedical research and HIPAA
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the "American Privacy Rights Act of 2024" provisions covering biomedical research and HIPAA
Affordable Housing Credit Improvement Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Affordable Housing Credit Improvement Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Affordable Housing Credit Improvement Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Affordable Housing Credit Improvement Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); UDI inclusion in Medicare claims form FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE)
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE) (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization; FDA modernization
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE) (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization; FDA modernization
American Innovation and R&D Competitiveness Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906); Name, Image and Likeness (NIL) collective charitable tax treatment; Athlete Opportunity and Taxpayer Integrity Act bill (S.___)
Affordable Housing Credit Improvement Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906); Name, Image and Likeness (NIL) collective charitable tax treatment; Athlete Opportunity and Taxpayer Integrity Act bill (S.___)
Affordable Housing Credit Improvement Act of 2023
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Research & development tax amortization (S.866); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906); Name, Image and Likeness (NIL) collective charitable tax treatment; Athlete Opportunity and Taxpayer Integrity Act bill (S.___)
Student Athlete Level Playing Field Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Name, Image and Likeness (NIL) issues: (H.R. 3630) Student Athlete Level Playing Field Act; Discussion draft bill re: NIL
Student Athlete Level Playing Field Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Name, Image and Likeness (NIL) issues: (H.R. 3630) Athlete Level Playing Field Act; Discussion Draft bill re: NIL
Student Athlete Level Playing Field Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Name, Image and Likeness (NIL) issues: (H.R. 3630) Student Athlete Level Playing Field Act; Discussion draft bill re: NIL
Medical Device Electronic Labeling Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE) (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization; FDA modernization
Medical Device Electronic Labeling Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization; FDA modernization
Medical Device Electronic Labeling Act
Client: THE COOK GROUP INC. · Firm: THE COOK GROUP INC.
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE) (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665) U.S.-China Board of Trade
Workforce Development
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities CMS NPRM IPPS proposal to repeal New Technology Add on Payment (NTAP) and Transitional Pass-Through pathway for FDA Breakthrough Devices; proposal for adoption of unique device identifier (UDI) capture measure under the Medicare Promoting Interoperability Program. Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153) Medicare Program: Regulatory Alignment for Predictable and Immediate Device Coverage Pathway (RAPID) Proposed Coverage Pathway proposal by CMS
Name, Image and Likeness (NIL) issue: "SCORE Act" (H.R. 4312)
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI. Right-to-Repair provision in House NDAA (H.R.4784/H.R. 8800) broadly would impact FDA regulated medical devices
Filing targets: Bureau of Industry and Security (BIS), HOUSE OF REPRESENTATIVES, SENATE
THE COOK GROUP INC. via THE COOK GROUP INC.
2026 · second_quarter · Q2
PFAS issues: Fluoro Polymers [Per- and polyfluoroalkyl] (PFAS) type(s) of substances used in medical devices
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI. Right-to-Repair provision in House NDAA H.R.4784/H.R. 8800 broadly would impact FDA regulated medical devices
Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)
Workforce Development
Name, Image and Likeness (NIL) issue: "SCORE Act" (H.R. 4312)
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities CMS NPRM IPPS proposal to repeal New Technology Add on Payment (NTAP) and Transitional Pass-Through pathway for FDA Breakthrough Devices; proposal for adoption of unique device identifier (UDI) capture measure under the Medicare Promoting Interoperability Program. Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153)
Filing targets: Bureau of Industry and Security (BIS), HOUSE OF REPRESENTATIVES, SENATE
THE COOK GROUP INC. via THE COOK GROUP INC.
2026 · first_quarter · Q1
Workforce Development
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153)
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI.
Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
Name, Image and Likeness (NIL) issue: "SCORE Act" (H.R. 4312)
PFAS issues: Fluoro Polymers [Per- and polyfluoroalkyl] (PFAS) type(s) of substances used in medical devices
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COOK GROUP INC. via THE COOK GROUP INC.
2025 · fourth_quarter · Q4
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement.
Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
Workforce Development
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)
Name, Image and Likeness (NIL) issue: "SCORE Act" H.R. 4312
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COOK GROUP INC. via THE COOK GROUP INC.
2025 · third_quarter · Q3
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement.
Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)
Beneficial Owner
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
Workforce Development
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)
Name, Image and Likeness (NIL) issue: "SCORE Act" H.R. 4312
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COOK GROUP INC. via THE COOK GROUP INC.
2025 · second_quarter · Q2
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT) Unique Device Identifier (UDI) in Medicare claims form FDA Reform: Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) FDA Modernization: modeling non-animal studies for medical device studies; Medical Device Electronic Labeling Act (H.R. 1539); draft legislation "Safe Medical Device Repair Act" third party right to repair Biotechnology: reduce regulatory barriers; align public-private investment Nursing Workforce Shortage
H.R. 1 the "One Big Beautiful Bill Act" specifically the TCJA Provisions: corporate tax rate; incentives to promote U.S. manufacturing; research and development amortization; bonus depreciation; construction of workforce housing; new market tax credit (H.R. 1103)
THE COOK GROUP INC. via THE COOK GROUP INC.
2025 · first_quarter · Q1
EPA Regulation of Ethylene Oxide NESHAP Rule and FIFRA Interim Decision Re-Registration PFAS issues: Fluoro Polymers [Per- and polyfluoroalkyl (PFAS) type(s) of substances used in medical devices]
Workforce Development
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (legislation pending); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT) Unique Device Identifier (UDI) in Medicare claims form FDA Reform: Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) FDA Modernization: modeling non-animal studies for medical device studies; Medical Device Electronic Labeling Act (H.R. 1539) Biotechnology: reduce regulatory barriers; align public-private investment Nursing Workforce Shortage
THE COOK GROUP INC. via THE COOK GROUP INC.
2024 · fourth_quarter · Q4
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
Patent legislation: beneficiary owner
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
THE COOK GROUP INC. via THE COOK GROUP INC.
2024 · third_quarter · Q3
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the "American Privacy Rights Act of 2024" provisions covering biomedical research and HIPAA
EPA regulation of Ethylene Oxide NESHAP Rule and Re-Registration FIFRA PID Rule PFAS issues: Fluoropolymers
THE COOK GROUP INC. via THE COOK GROUP INC.
2024 · second_quarter · Q2
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the "American Privacy Rights Act of 2024" provisions covering biomedical research and HIPAA
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
THE COOK GROUP INC. via THE COOK GROUP INC.
2024 · first_quarter · Q1
Patent legislation: beneficiary owner
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
EPA regulation of Ethylene Oxide NESHAP Rule and Re-Registration FIFRA PID Rule PFAS issues: Fluoropolymers
THE COOK GROUP INC. via THE COOK GROUP INC.
2023 · fourth_quarter · Q4
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906); Name, Image and Likeness (NIL) collective charitable tax treatment; Athlete Opportunity and Taxpayer Integrity Act bill (S.___)
Workforce Development; primary and secondary education reading program(s) (readable English)
EPA regulation of Ethylene Oxide PFAS issues: Fluoropolymers
THE COOK GROUP INC. via THE COOK GROUP INC.
2023 · third_quarter · Q3
Research & development tax amortization (S.866); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906); Name, Image and Likeness (NIL) collective charitable tax treatment; Athlete Opportunity and Taxpayer Integrity Act bill (S.___)
Workforce Development; primary and secondary education reading program(s) (readable English)
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
THE COOK GROUP INC. via THE COOK GROUP INC.
2023 · second_quarter · Q2
Name, Image and Likeness (NIL) issues: (H.R. 3630) Athlete Level Playing Field Act; Discussion Draft bill re: NIL
Workforce Development; primary and secondary education reading program(s) (readable English)
Research & development tax amortization (S.866); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557); Rural Opportunity Zone and Investment Act (H.R. 3906); Name, Image and Likeness (NIL) collective charitable tax treatment; Athlete Opportunity and Taxpayer Integrity Act bill (S.___)
THE COOK GROUP INC. via THE COOK GROUP INC.
2023 · first_quarter · Q1
EPA regulation of Ethylene Oxide PFAS issues: Fluoro Polymers
Research & development tax amortization (S.866); neighborhood homes investment tax credit bill (S.657); Name, Image and Likeness (NIL) collective charitable tax treatment
Patent legislation: beneficiary owner
THE COOK GROUP INC. via THE COOK GROUP INC.
2022 · fourth_quarter · Q4
New Road Corridor in Indiana
Patent Litigation Reform Pride in Patent Ownership Act (S.2774)
Workforce Development Increase maximum allowable tuition assistance support Manufacturing sector: industry recognized advanced targeted credentials Career and technical education programs focus on high-demand industry sectors Childcare Programs: education and training childcare providers' workforce to increase capacity
THE COOK GROUP INC. via THE COOK GROUP INC.
2022 · third_quarter · Q3
Medicare Program Medicare Reimbursement: Transitional Coverage of Emerging Technologies; Medicare coverage of breakthrough technologies (HR 4043); coverage with evidence development (CED); inclusion of UDI in claims forms; physician reimbursement: clinical labor update; graduate medical education Use of real world data and real world evidence FDA Reform COVID-19 FDA reporting requirements under Public Health Emergency (CARES Act) COVID-19 CARES Act funding for rural hospitals; expanded use of telehealth Medical device supply chain Medical device shortage reporting Domestic production of medical products FDA Emerging Postmarket Medical Device Signals Communication PREVENT Act Medical Device User Fees and FDA Reform bills: FDASLA and FDA Amendments of 2022 Predetermined Change Protocols Program
Tax Reform (Tax Cut and Jobs Act of 2017): Capitalization of Research & Development (R&D) Expenses; R&D tax amortization (HR 1304); Foreign Derived Intangible Income (FDII); GILTI Manufacturing equipment refundable tax credit American Innovation and Jobs Act/America COMPETES Act Tax Credit Bond Proceeds for infrastructure Excise tax on taxable virgin plastic resin (REDUCE Act of 2021) Retirement Security bill, Secure II Act
THE COOK GROUP INC. via THE COOK GROUP INC.
2022 · second_quarter · Q2
Workforce Development Increase maximum allowable tuition assistance support Manufacturing sector: industry recognized advanced targeted credentials Career and technical education programs focus on high-demand industry sectors Childcare Programs: education and training childcare providers' workforce to increase capacity
Medicare Program Medicare Reimbursement: Transitional Coverage of Emerging Technologies; Medicare Coverage of Innovative Technology pathway; Medicare coverage of breakthrough technologies (HR 4043); coverage with evidence development (CED); inclusion of UDI in claims forms; physician reimbursement: clinical labor update; graduate medical education Use of real world data and real world evidence FDA Reform COVID-19 FDA reporting requirements under Public Health Emergency (CARES Act) COVID-19 CARES Act funding for rural hospitals; expanded use of telehealth Medical device supply chain Medical device shortage reporting Domestic production of medical products FDA Emerging Postmarket Medical Device Signals Communication PREVENT Act Medical Device User Fees and FDA Reform bills: FDASLA and FDA Amendments of 2022
THE COOK GROUP INC. via THE COOK GROUP INC.
2022 · first_quarter · Q1
Tax Reform (Tax Cut and Jobs Act of 2017):Capitalization of Research & Development (R&D) Expenses; R&D tax amortization (HR 1304); Foreign Derived Intangible Income (FDII); GILTI; corporate tax rate Net operating loss (CARES Act) Manufacturing equipment refundable tax credit American Innovation and Jobs Act/America COMPETES Act Tax Credit Bond Proceeds for infrastructure Excise tax on taxable virgin plastic resin (REDUCE Act of 2021)
Workforce Housing Programs: USDA Section 502 for low-income, rural areas in need of affordable housing
Medicare Program Medicare Reimbursement: Transitional Coverage of Emerging Technologies; Medicare Coverage of Innovative Technology pathway; Medicare coverage of breakthrough technologies (HR 4043); coverage with evidence development (CED); inclusion of UDI in claims forms; physician reimbursement: clinical labor update; graduate medical education Value-Based Health Care Use of real world data and real world evidence FDA Reform COVID-19 FDA reporting requirements under Public Health Emergency (CARES Act) COVID-19 CARES Act funding for rural hospitals; expanded use of telehealth Medical device supply chain Medical device shortage reporting Domestic production of medical products FDA Emerging Postmarket Medical Device Signals Communication PREVENT Act
THE COOK GROUP INC. via THE COOK GROUP INC.
2021 · fourth_quarter · Q4
Workforce Housing Programs: USDA Section 502 for low-income, rural areas in need of affordable housing
Workforce Development Increase maximum allowable tuition assistance support Manufacturing sector: industry recognized advanced targeted credentials Career and technical education programs focus on high-demand industry sectors American Rescue Plan: workforce provisions Childcare Programs: education and training childcare providers' workforce to increase capacity
New Road Corridor in Indiana
THE COOK GROUP INC. via THE COOK GROUP INC.
2021 · third_quarter · Q3
Patent Litigation Reform
Workforce Development Increase maximum allowable tuition assistance support Manufacturing sector: industry recognized advanced targeted credentials Career and technical education programs focus on high-demand industry sectors American Rescue Plan: workforce provisions Childcare Programs: education and training childcare providers' workforce to increase capacity
Workforce Housing Programs: USDA Section 502 for low-income, rural areas in need of affordable housing
THE COOK GROUP INC. via THE COOK GROUP INC.
2021 · second_quarter · Q2
Patent Litigation Reform
Medicare Program Medicare Reimbursement: Medicare Coverage of Innovative Technology pathway; coverage with evidence development (CED); inclusion of UDI in claims forms Value-Based Health Care FDA Reform COVID-19 FDA reporting requirements under Public Health Emergency (CARES Act) COVID-19 CARES Act funding for rural hospitals; expanded use of telehealth Medical device supply chain Domestic production of medical products
Workforce Development Increase maximum allowable tuition assistance support Manufacturing sector: industry recognized advanced targeted credentials Career and technical education programs focus on high-demand industry sectors American Rescue Plan: workforce provisions
THE COOK GROUP INC. via THE COOK GROUP INC.
2021 · first_quarter · Q1
New Road Corridor in Indiana
Workforce Development Increase maximum allowable tuition assistance support Manufacturing sector: industry recognized advanced targeted credentials Career and technical education programs focus on high-demand industry sectors American Rescue Plan: workforce provisions
Patent Litigation Reform
THE COOK GROUP INC. via THE COOK GROUP INC.
2020 · fourth_quarter · Q4
Civil Litigation: transparency of third party financing legislation COVID-19 pandemic legal liability reform
Veterans Health Administration Procurement
New Road Corridor in Indiana
THE COOK GROUP INC. via THE COOK GROUP INC.
2020 · third_quarter · Q3
U.S.-Japan trade agreement regarding pricing of medical devices European Union's Medical Device Regulation impact on U.S. products
Patent Litigation Reform Legislation
Veterans Health Administration Procurement
THE COOK GROUP INC. via THE COOK GROUP INC.
2020 · second_quarter · Q2
U.S.-Japan trade agreement regarding pricing of medical devices European Union's Medical Device Regulation impact on U.S. products
Patent Litigation Reform Legislation
New Road Corridor in Indiana
THE COOK GROUP INC. via THE COOK GROUP INC.
2020 · first_quarter · Q1
USMCA trade agreement U.S.-Japan trade agreement regarding pricing of medical devices European Union's Medical Device Regulation impact on U.S. products
Civil Litigation: transparency of third party financing legislation
Veterans Health Administration Procurement
THE COOK GROUP INC. via THE COOK GROUP INC.
2019 · fourth_quarter · Q4
U.S.-China Retaliatory Tariffs Negotiation
Excise Tax on Medical Devices International Tax Tax Extenders
Civil Litigation: transparency of third party financing legislation
THE COOK GROUP INC. via THE COOK GROUP INC.
2019 · third_quarter · Q3
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Health Care Reform Legislation FDA Reform FDA Regulatory Preemption Legislation Medicare Program
USMCA trade agreement U.S.-Japan trade agreement regarding pricing of medical devices European Union's Medical Device Regulation impact on U.S. products
THE COOK GROUP INC. via THE COOK GROUP INC.
2019 · second_quarter · Q2
Patent Litigation Reform Legislation
Veterans Health Administration Procurement
Excise Tax on Medical Devices International Tax Corporate Tax Reform
THE COOK GROUP INC. via THE COOK GROUP INC.
2019 · first_quarter · Q1
Patent Litigation Reform Legislation
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Health Care Reform Legislation FDA Reform Medicare Program
THE COOK GROUP INC. via THE COOK GROUP INC.
2018 · fourth_quarter · Q4
Patent Litigation Reform Legislation
Veterans Health Administration Procurement
Health Care Reform Legislation FDA Reform Medicare Program
THE COOK GROUP INC. via THE COOK GROUP INC.
2018 · third_quarter · Q3
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Patent Litigation Reform Legislation
Veterans Health Administration Procurement
THE COOK GROUP INC. via THE COOK GROUP INC.
2018 · second_quarter · Q2
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Patent Litigation Reform Legislation
Veterans Health Administration Procurement
THE COOK GROUP INC. via THE COOK GROUP INC.
2018 · first_quarter · Q1
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Health Care Reform Legislation FDA Reform Medicare Program
Veterans Health Administration Procurement
THE COOK GROUP INC. via THE COOK GROUP INC.
2017 · fourth_quarter · Q4
Veterans Health Administration Procurement
Tort Reform Legislation
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
THE COOK GROUP INC. via THE COOK GROUP INC.
2017 · third_quarter · Q3
Health Care Reform Legislation FDA Reform MDUFA IV Medicare Program
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Tort Reform Legislation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2017 · second_quarter · Q2
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Tort Reform Legislation
Health Care Reform Legislation FDA Reform MDUFA IV Medicare Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2017 · first_quarter · Q1
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Health Care Reform Legislation FDA Reform MDUFA IV Unique Device Identification Medicare Program
Tort Reform Legislation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2016 · fourth_quarter · Q4
Health Care Reform Legislation FDA Reform Women's Health Vendor Credentialing Unique Device Identification Medicare Program 21st Century Cures Legislation
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Patent Litigation Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2016 · third_quarter · Q3
Health Care Reform Legislation FDA Reform Women's Health Vendor Credentialing Unique Device Identification Medicare Program
Patent Litigation Reform
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2016 · second_quarter · Q2
Patent Litigation Reform
Health Care Reform Legislation FDA Reform Women's Health Vendor Credentialing Unique Device Identification Medicare Program
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2016 · first_quarter · Q1
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Patent Litigation Reform
Health Care Reform Legislation FDA Reform Women's Health Vendor Credentialing Unique Device Identification Medicare Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2015 · fourth_quarter · Q4
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Health Care Reform Legislation FDA Reform Women's Health Vendor Credentialing Unique Device Identification Medicare Program
Patent Litigation Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2015 · third_quarter · Q3
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Health Care Reform Legislation FDA Reform Women's Health Vendor Credentialing Unique Device Identification Medicare Program
Patent Litigation Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2015 · second_quarter · Q2
Patent Litigation Reform
Health Care Reform Legislation FDA Reform Emergency Preparedness Women's Health Vendor Credentialing Unique Device Identification
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2015 · first_quarter · Q1
Health Care Reform Legislation FDA Reform Emergency Preparedness Women's Health Vendor Credentialing
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Patent Litigation Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2014 · fourth_quarter · Q4
Health Care Reform Legislation FDA Reform Emergency Preparedness Women's Health
Patent Litigation Reform
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
THE COOK GROUP INC. via THE COOK GROUP INC.
2014 · third_quarter · Q3
Patent Litigation Reform
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Health Care Reform Legislation FDA Reform Emergency Preparedness Women's Health
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
THE COOK GROUP INC. via THE COOK GROUP INC.
2014 · second_quarter · Q2
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Patent Litigation Reform
Health Care Reform Legislation FDA Reform Emergency Preparedness Women's Health
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of
THE COOK GROUP INC. via THE COOK GROUP INC.
2014 · first_quarter · Q1
Health Care Reform Legislation FDA reform Emergency Preparedness Women's Health
AAA Screening
Excise Tax on Medical Devices International Tax Corporate Tax Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2013 · fourth_quarter · Q4
AAA Screening
Deferral Excise Tax on Medical Devices International Tax Corporate Tax Reform
Health Care Reform Legislation FDA Reform Emergency Preparedness Women's Health
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2013 · third_quarter · Q3
Health Care Reform Legislation FDA Reform Emergency Preparedness
Deferral Excise Tax on Medical Devices International Tax Corporate Tax Reform
AAA Screening
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2013 · second_quarter · Q2
AAA Screening
Health Care Reform Legislation FDA Reform Emergency Preparedness
Deferral Excise Tax on Medical Devices International Tax Corporate Tax Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2013 · first_quarter · Q1
AAA Screening
Health Care Reform Legislation FDA Reform Emergency Preparedness
Deferral Excise Tax on Medical Devices International Tax Corporate Tax Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of, White House Office
THE COOK GROUP INC. via THE COOK GROUP INC.
2012 · fourth_quarter · Q4
Deferral Excise Tax on Medical Devices International Tax Corporate Tax Reform
Health Care Reform Legislation FDA Reform Emergency Preparedness
AAA Screening
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
THE COOK GROUP INC. via THE COOK GROUP INC.
2012 · third_quarter · Q3
Deferral Excise Tax on Medical Devices International Tax Corporate Tax Reform
AAA Screening
Health Care Reform Legislation FDA Reform Emergency Preparedness
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
THE COOK GROUP INC. via THE COOK GROUP INC.
2012 · second_quarter · Q2
Health Care Reform Legislation FDA Reform FDA User Fees Reauthorization Emergency Preparedness
AAA Screening
Deferral Excise Tax on Medical Devices International Tax Corporate Tax Reform
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
THE COOK GROUP INC. via THE COOK GROUP INC.
2012 · first_quarter · Q1
AAA Screening
Deferral Excise Tax on Medical Devices International Tax Corporate Tax Reform
Health Care Reform Legislation FDA Reform FDA User Fees Reauthorization Emergency Preparedness
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of
THE COOK GROUP INC. via THE COOK GROUP INC.
2011 · fourth_quarter · Q4
Deferral Excise Tax on Medical Devices International Tax Corporate Tax Reform
AAA Screening
Health Care Reform Legislation FDA Reform FDA User Fees Reauthorization Emergency Preparedness Primary Care Health Workforce
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of
THE COOK GROUP INC. via THE COOK GROUP INC.
2011 · third_quarter · Q3
Health Care Reform Legislation Comparative Effectiveness Research FDA Reform Emergency Preparedness Primary Care Health Workforce
Deferral Excise Tax on Medical Devices International Tax
AAA Screening
THE COOK GROUP INC. via THE COOK GROUP INC.
2011 · second_quarter · Q2
Deferral Excise Tax on Medical Devices International Tax
Patent Reform Legislation
Health Care Reform Legislation Comparative Effectiveness Research FDA Reform Emergency Preparedness Primary Care Health Workforce
THE COOK GROUP INC. via THE COOK GROUP INC.
2011 · first_quarter · Q1
Deferral Excise Tax on Medical Devices International Tax
AAA Screening PAD Screening
Patent Reform Legislation
THE COOK GROUP INC. via THE COOK GROUP INC.
2010 · fourth_quarter · Q4
Patent Reform Legislation
Private Investment Act
Health Care Reform Legislation Physician Payments Sunshine Act Comparative Effectiveness Research FDA Reform Emergency Preparedness Primary Care Health Workforce
THE COOK GROUP INC. via THE COOK GROUP INC.
2010 · third_quarter · Q3
Health Care Reform Legislation Physician Payments Sunshine Act Comparative Effectiveness Research FDA Reform Emergency Preparedness Primary Care Health Workforce
AAA Screening PAD Screening
Deferral Excise Tax on Medical Devices International Tax
THE COOK GROUP INC. via THE COOK GROUP INC.
2010 · second_quarter · Q2
Health Care Reform Legislation Physician Payments Sunshine Act Comparative Effectiveness Research FDA Reform
Patent Reform Legislation
AAA Screening PAD Screening
THE COOK GROUP INC. via THE COOK GROUP INC.
2010 · first_quarter · Q1
Patent Reform Legislation
Health Care Reform Legislation Physician Payments Sunshine Act Comparative Effectiveness Research FDA Reform
Deferral Excise Tax on Medical Devices
THE COOK GROUP INC. via THE COOK GROUP INC.
2009 · fourth_quarter · Q4
Health Reform Legislatiion FDA Reform Physician Payments Sunshine Act FDA Appropriations Comparative Effectiveness Reseasrch FDA Preemption
Tax Reform
Financial Servoces REfrom
THE COOK GROUP INC. via THE COOK GROUP INC.
2009 · third_quarter · Q3
Patent Reform Legislation
Deferral Excise Tax on Medical Devices
AAA Screening PAD Screening
THE COOK GROUP INC. via THE COOK GROUP INC.
2009 · second_quarter · RA
Health Care Reform Legislation FDA Preemption Tax Deferral Physician Payments Sunshine Act FDA Reform AAA Screening PAD Screening Comaprative Effectivness Research Patent Reform
Health Care Reform Legislation FDA Preemption Tax Deferral Physician Payments Sunshine Act FDA Reform AAA Screening PAD Screening Comaprative Effectivness Research Patent Reform
Health Care Reform Legislation FDA Preemption Tax Deferral Physician Payments Sunshine Act FDA Reform AAA Screening PAD Screening Comaprative Effectivness Research Patent Reform
THE COOK GROUP INC. via THE COOK GROUP INC.
2009 · second_quarter · Q2
Patent Reform Legislation
AAA Screening PAD Screening
Health Care Reform Legislation FDA Reform Physician Payments Sunshine Act FDA Appropriations Comparative Effectiveness Research FDA Preemption
Beneficial Owner
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
EPA Regulation of Ethylene Oxide NESHAP Rule and FIFRA Interim Decision Re-Registration PFAS issues: Fluoro Polymers [Per- and polyfluoroalkyl (PFAS) type(s) of substances used in medical devices]
Workforce Development
Tariffs levied by the Administration
NIL issue: "SCORE Act" draft legislation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TCJA Provisions: corporate tax rate; incentives to promote U.S. manufacturing; research and development amortization; bonus depreciation; construction of workforce housing; new market tax credit (H.R. 1103)
Beneficial Owner
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the "American Privacy Rights Act of 2024" provisions covering biomedical research and HIPAA
EPA regulation of Ethylene Oxide NESHAP Rule and Re-Registration FIFRA PID Rule PFAS issues: Fluoropolymers
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patent legislation: beneficiary owner
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
EPA regulation of Ethylene Oxide NESHAP Rule and Re-Registration FIFRA PID Rule PFAS issues: Fluoropolymers
Patent legislation: beneficiary owner
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization; FDA modernization
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
Name, Image and Likeness (NIL) issues: (H.R. 3630) Student Athlete Level Playing Field Act; Discussion draft bill re: NIL
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization; FDA modernization
Patent legislation: beneficiary owner
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EPA regulation of Ethylene Oxide PFAS issues: Fluoropolymers
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE) (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization; FDA modernization
Name, Image and Likeness (NIL) issues: (H.R. 3630) Student Athlete Level Playing Field Act; Discussion draft bill re: NIL
Patent legislation: beneficiary owner
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patent legislation: beneficiary owner
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
EPA regulation of Ethylene Oxide PFAS issues: Fluoro Polymers
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE) (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); UDI inclusion in Medicare claims form FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE)
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
Name, Image and Likeness (NIL) issues
Workforce Development; primary and secondary education reading program(s) (readable English)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Tax Reform (Tax Cut and Jobs Act of 2017): Capitalization of Research & Development (R&D) Expenses; R&D tax amortization (HR 1304); Foreign Derived Intangible Income (FDII); GILTI Manufacturing equipment refundable tax credit Tax Credit Bond Proceeds for infrastructure Excise tax on taxable virgin plastic resin (REDUCE Act of 2021) Retirement Security bill, Secure II Act
Workforce Housing Programs: USDA Section 502 for low-income, rural areas in need of affordable housing
Medicare Program Medicare Reimbursement: Transitional Coverage of Emerging Technologies; Medicare coverage of breakthrough technologies (HR 4043); coverage with evidence development (CED); inclusion of UDI in claims forms; physician reimbursement: clinical labor update; graduate medical education Use of real world data and real world evidence FDA Reform COVID-19 FDA reporting requirements under Public Health Emergency (CARES Act) COVID-19 CARES Act funding for rural hospitals; expanded use of telehealth Medical device supply chain Medical device shortage reporting Domestic production of medical products FDA Emerging Postmarket Medical Device Signals Communication PREVENT Act Medical Device User Fees (FDA Omnibus Reform Act) and FDA Reform bills: FDASLA and FDA Amendments of 2022 Predetermined Change Protocols Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
New Road Corridor in Indiana
Patent Litigation Reform
Workforce Development Increase maximum allowable tuition assistance support Manufacturing sector: industry recognized advanced targeted credentials Career and technical education programs focus on high-demand industry sectors Childcare Programs: education and training childcare providers' workforce to increase capacity
Workforce Housing Programs: USDA Section 502 for low-income, rural areas in need of affordable housing
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patent Litigation Reform
Workforce Housing Programs: USDA Section 502 for low-income, rural areas in need of affordable housing
New Road Corridor in Indiana
Tax Reform (Tax Cut and Jobs Act of 2017): Capitalization of Research & Development (R&D) Expenses; R&D tax amortization (HR 1304); Foreign Derived Intangible Income (FDII); GILTI Manufacturing equipment refundable tax credit American Innovation and Jobs Act/America COMPETES Act Tax Credit Bond Proceeds for infrastructure Excise tax on taxable virgin plastic resin (REDUCE Act of 2021)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Workforce Development Increase maximum allowable tuition assistance support Manufacturing sector: industry recognized advanced targeted credentials Career and technical education programs focus on high-demand industry sectors American Rescue Plan: workforce provisions Childcare Programs: education and training childcare providers' workforce to increase capacity
New Road Corridor in Indiana
Patent Litigation Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Tax Reform (Tax Cut and Jobs Act of 2017):Capitalization of Research & Development Expenses; Foreign Derived Intangible Income (FDII); GILTI; corporate tax rate Net operating loss (CARES Act) Manufacturing equipment refundable tax credit American Innovation and Jobs Act Tax Credit Bond Proceeds for infrastructure Excise tax on taxable virgin plastic resin (REDUCE Act of 2021)
Medicare Program Medicare Reimbursement: Medicare Coverage of Innovative Technology pathway; coverage with evidence development (CED); inclusion of UDI in claims forms; physician reimbursement; graduate medical education Value-Based Health Care FDA Reform COVID-19 FDA reporting requirements under Public Health Emergency (CARES Act) COVID-19 CARES Act funding for rural hospitals; expanded use of telehealth Medical device supply chain Domestic production of medical products
Patent Litigation Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
New Road Corridor in Indiana
Medicare Program Medicare Reimbursement: Medicare Coverage of Innovative Technology pathway; coverage with evidence development (CED); inclusion of UDI in claims forms; physician reimbursement; graduate medical education Value-Based Health Care FDA Reform COVID-19 FDA reporting requirements under Public Health Emergency (CARES Act) COVID-19 CARES Act funding for rural hospitals; expanded use of telehealth Medical device supply chain Domestic production of medical products
Tax Reform (Tax Cut and Jobs Act of 2017):Capitalization of Research & Development Expenses; Foreign Derived Intangible Income (FDII); GILTI; corporate tax rate Net operating loss (CARES Act) Manufacturing equipment refundable tax credit American Innovation and Jobs Act Tax Credit Bond Proceeds for infrastructure
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Tax Reform (Tax Cut and Jobs Act of 2017):Capitalization of Research & Development Expenses; Foreign Derived Intangible Income (FDII); GILTI; corporate tax rate Net operating loss (CARES Act) Manufacturing equipment refundable tax credit American Innovation and Jobs Act
New Road Corridor in Indiana
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Tax Reform (Tax Cut and Jobs Act of 2017):Capitalization of Research & Development Expenses; Foreign Derived Intangible Income (FDII); GILTI; corporate tax rate Net operating loss (CARES Act) Manufacturing equipment refundable tax credit American Innovation and Jobs Act
Medicare Program Medicare Reimbursement: Medicare Coverage of Innovative Technology pathway; coverage with evidence development (CED); inclusion of UDI in claims forms Value-Based Health Care FDA Reform COVID-19 FDA reporting requirements under Public Health Emergency (CARES Act) COVID-19 CARES Act funding for rural hospitals; expanded use of telehealth Medical device supply chain Domestic production of medical products Ethylene oxide sterilization of medical products
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patent Litigation Reform Legislation
U.S.-China Retaliatory Tariffs Negotiation
Health Care Reform Legislation FDA Reform FDA Regulatory Preemption Legislation Ethylene Oxide Sterilization of Medical Devices Medicare Program Value-Based Health Care Medicare Reimbursement: inclusion of Unique Device Identification (UDI) in insurance claims forms COVID-19 FDA Reporting Requirements under Public Health Emergency (CARES Act) COVID-19 CARES Act funding for rural hospitals; streamline credentialing process COVID-19 CARES Act expanded use of telehealth and remote monitoring Medical Device Supply Chain
U.S.-Japan trade agreement regarding pricing of medical devices European Union's Medical Device Regulation impact on U.S. products
Foreign Derived Intangible Income (FDII) Capitalization of Research & Development Expenses (Tax Cuts and Jobs Act of 2017) Manufacturing equipment refundable tax credit COVID-19 CARES Act net operating loss tax provision
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Civil Litigation: transparency of third party financing legislation COVID-19 pandemic legal liability reform
U.S.-China Retaliatory Tariffs Negotiation
Health Care Reform Legislation FDA Reform FDA Regulatory Preemption Legislation Ethylene Oxide Sterilization of Medical Devices Medicare Program Value-Based Health Care Medicare Reimbursement: inclusion of Unique Device Identification (UDI) in insurance claims forms COVID-19 FDA Reporting Requirements under Public Health Emergency (CARES Act) COVID-19 CARES Act funding for rural hospitals; streamline credentialing process COVID-19 CARES Act expanded use of telehealth and remote monitoring Medical Device Supply Chain
New Road Corridor in Indiana
Foreign Derived Intangible Income (FDII) Capitalization of Research & Development Expenses (Tax Cuts and Jobs Act of 2017) Manufacturing equipment refundable tax credit COVID-19 CARES Act net operating loss tax provision
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Health Care Reform Legislation FDA Reform FDA Regulatory Preemption Legislation Ethylene Oxide Sterilization of Medical Devices Medicare Program Value-Based Health Care Medicare Reimbursement: inclusion of Unique Device Identification (UDI) in insurance claims forms COVID-19 FDA Reporting Requirements under Public Health Emergency (CARES Act) COVID-19 CARES Act funding for rural hospitals; streamline credentialing process COVID-19 CARES Act expanded use of telehealth and remote monitoring Medical Device Supply Chain
U.S.-China Retaliatory Tariffs Negotiation
Civil Litigation: transparency of third party financing legislation COVID-19 pandemic legal liability reform
Veterans Health Administration Procurement
Foreign Derived Intangible Income (FDII) Capitalization of Research & Development Expenses (Tax Cuts and Jobs Act of 2017) Manufacturing equipment refundable tax credit
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
New Road Corridor in Indiana
U.S.-China Retaliatory Tariffs Negotiation
Health Care Reform Legislation FDA Reform FDA Regulatory Preemption Legislation Ethylene Oxide Sterilization of Medical Devices Medicare Program Value-Based Health Care Medicare Reimbursement: inclusion of Unique Device Identification (UDI) in insurance claims forms COVID-19 FDA Reporting Requirements under Public Health Emergency (CARES Act)
Patent Litigation Reform Legislation
Excise Tax on Medical Devices
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Veterans Health Administration Procurement
Patent Litigation Reform Legislation
USMCA trade agreement U.S.-Japan trade agreement regarding pricing of medical devices European Union's Medical Device Regulation impact on U.S. products
Health Care Reform Legislation FDA Reform FDA Regulatory Preemption Legislation Ethylene Oxide Sterilization of Medical Devices Medicare Program Value-Based Health Care Medicare Reimbursement: inclusion of Unique Device Identification (UDI) in insurance claims forms
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Patent Litigation Reform Legislation
Veterans Health Administration Procurement
U.S.-China Retaliatory Tariffs Negotiation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
U.S.-China Retaliatory Tariffs Negotiation
Health Care Reform Legislation FDA Reform FDA Regulatory Preemption Legislation Medicare Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Veterans Health Administration Procurement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Excise Tax on Medical Devices International Tax Corporate Tax Reform Tax Extenders
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Health Care Reform Legislation FDA Reform Medicare Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Health Care Reform Legislation FDA Reform Medicare Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Patent Litigation Reform Legislation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Patent Litigation Reform Legislation
Health Care Reform Legislation FDA Reform MDUFA IV Medicare Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
Patent Reform Legislation
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Patent & Trademark Office (PTO), SENATE
AAA Screening
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of
Health Care Reform Legislation Physician Payments Sunshine Act Comparative Effectiveness Research FDA Reform Emergency Preparedness Primary Care Health Workforce
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of
AAA Screening PAD Screening
Deferral Excise Tax on Medical Devices International Tax
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of
Private Investment Act
Patent Reform Legislation
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of
Deferral Excise Tax on Medical Devices
Private Investment Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Patent & Trademark Office (PTO), SENATE
AAA Screening PAD Screening
Private Investment Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Patent & Trademark Office (PTO), SENATE
Patent REform Legislation
AAA Screening PAD Screening
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Patent & Trademark Office (PTO), SENATE
Health Care Reform Legislation Physician Payments Sunshine Act Comparative Effectiveness Research FDA Preemption
Private Investment Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Patent & Trademark Office (PTO), SENATE
Health Care Reform Legislation FDA Preemption Tax Deferral Physician Payments Sunshine Act FDA Reform AAA Screening PAD Screening Comaprative Effectivness Research Patent Reform
Deferral
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Patent & Trademark Office (PTO), SENATE